Shanghai RAAS Blood Products announced that its shareholder Grifols, S.A. has agreed to transfer 20% of the company's shares to Haiying Kang. According to the "Confirmation Letter on Share Transfer Agreements of Listed Companies in Shenzhen Stock Exchange" issued by Shenzhen Stock Exchange and the "Confirmation Letter on Securities Transfer Registration" issued by China Securities Depository and Clearing Co., Ltd. Shenzhen Branch, the equity change has been confirmed to be compliant with the agreement for transfer through Shenzhen Stock Exchange and the relevant share transfer registration procedures were completed on June 18, 2024.
上海莱士：股东Grifols,S.A.协议转让公司20%股份予海盈康已完成过户登记手续
Shanghai RAAS Blood Products: Shareholder Grifols, S.A. has completed the transfer of 20% of the company's shares to Haiying Kang after registration formalities.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.